neuroendocrine tumors

Showing 1 - 25 of 281

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

Completed
  • Neuroendocrine Tumors
  • Innsbruck, Austria
    Department of Nuclear Medicine, Medical University of Innsbruck
Nov 24, 2023

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Clinical Relevance of Salvage Treatment for Colorectal

Completed
  • Rectal Neoplasms
  • Neuroendocrine Tumors
  • salvage treatment
  • (no location specified)
Nov 16, 2023

Neuroendocrine Tumors Trial in Hyderabad (Endoscopic submucosal dissection, EFTR)

Recruiting
  • Neuroendocrine Tumors
  • Endoscopic submucosal dissection
  • EFTR
  • Hyderabad, Telangana, India
    Asian institute of Gastroenterology
Nov 11, 2023

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting
  • Neuroendocrine Tumors
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Nov 2, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • (no location specified)
Sep 13, 2023

Neuroendocrine Tumors Trial in Beijing (Surufatinib Combined With Temozolomide and S-1)

Not yet recruiting
  • Neuroendocrine Tumors
  • Surufatinib Combined With Temozolomide and S-1
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 8, 2023

Imaging Features in Invasiveness and Prognosis of Pituitary

Recruiting
  • Pituitary Adenoma
  • Neuroendocrine Tumors
  • diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Aug 24, 2023

Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Newport Beach, California
  • +2 more
Aug 16, 2023

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • (no location specified)
Aug 9, 2023

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Not yet recruiting
  • Neuroendocrine Tumors
    • San Francisco, California
      Power Life Sciences
    Jul 21, 2023

    Collect Somatuline® Injector Device Preferences of Patients

    Not yet recruiting
    • Neuroendocrine Tumors
      • (no location specified)
      Jun 19, 2023

      Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

      Not yet recruiting
      • Neuroendocrine Tumors
      • Lutetium[177Lu] Oxodotreotide Injection
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      May 30, 2023

      Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

      Recruiting
      • Neuroendocrine Tumors
      • Innsbruck, Austria
      • +2 more
      May 12, 2023

      Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)

      Recruiting
      • Neuroendocrine Tumors
      • Peptide Receptor Radionuclide Therapy
      • Rotterdam, South Holland, Netherlands
        Erasmus MC
      May 19, 2023

      Cancer of Stomach, Oesophageal Cancer, Gastric Cancer Trial in Sydney

      Recruiting
      • Cancer of Stomach
      • +8 more
        • Sydney, New South Wales, Australia
          Westmead Hospital
        Mar 26, 2023

        Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San

        Not yet recruiting
        • Neuroendocrine Tumors
        • +2 more
        • San Francisco, California
          University of California, San Francisco
        Feb 17, 2023

        GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

        Enrolling by invitation
        • GEP-NET
        • +3 more
        • Copenhagen, Denmark
          Rigshospitalet
        Jan 24, 2023

        VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

        Recruiting
        • VHL Pancreatic Neuroendocrine Tumors
        • +2 more
        • 68-Gallium DOTATATE
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2023

        Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Stanford (Serious Illness Conversation Guide

        Terminated
        • Gastrointestinal Cancer
        • +8 more
        • Serious Illness Conversation Guide (SICG)
        • Quality of Life (QOL) survey
        • Stanford, California
          Stanford Cancer Center
        Jan 25, 2023

        Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

        Active, not recruiting
        • Neuroendocrine Tumors
        • +2 more
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Jan 24, 2023

        GastroIntestinal Cancer in Children and Adolescents

        Active, not recruiting
        • Gastrointestinal Cancer
        • +6 more
          • Leiden, South-Holland, Netherlands
          • +1 more
          Jan 11, 2023